PeopleBio Past Earnings Performance
Past criteria checks 0/6
PeopleBio's earnings have been declining at an average annual rate of -40.6%, while the Biotechs industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 46.3% per year.
Key information
-40.6%
Earnings growth rate
-32.2%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | 46.3% |
| Return on equity | -114.7% |
| Net Margin | -296.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How PeopleBio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,459 | -13,209 | 9,316 | 4,058 |
| 31 Mar 24 | 4,149 | -13,587 | 9,458 | 4,058 |
| 31 Dec 23 | 4,453 | -16,035 | 10,370 | 5,160 |
| 30 Sep 23 | 4,076 | -22,172 | 13,549 | 4,155 |
| 30 Jun 23 | 4,588 | -21,328 | 12,399 | 4,155 |
| 31 Mar 23 | 4,967 | -17,395 | 10,942 | 4,588 |
| 31 Dec 22 | 4,445 | -14,303 | 8,692 | 3,390 |
| 30 Sep 22 | 3,690 | -3,494 | 5,597 | 2,646 |
| 30 Jun 22 | 2,429 | -2,779 | 4,869 | 2,646 |
| 31 Mar 22 | 1,094 | -5,919 | 2,763 | 3,338 |
| 31 Dec 21 | 577 | -4,697 | 3,728 | 2,119 |
| 30 Sep 21 | 632 | -7,853 | 3,611 | 2,276 |
| 31 Dec 20 | 508 | -4,383 | 2,333 | 1,891 |
Quality Earnings: A304840 is currently unprofitable.
Growing Profit Margin: A304840 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A304840 is unprofitable, and losses have increased over the past 5 years at a rate of 40.6% per year.
Accelerating Growth: Unable to compare A304840's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A304840 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (6.1%).
Return on Equity
High ROE: A304840 has a negative Return on Equity (-114.74%), as it is currently unprofitable.